AnaptysBio Inc.

ANAB | NASDAQ

Price Alert Chart Builder DCF Calculator

$55.10

-$0.10 (-0.18%)

Sep 21, 2026, 12:37 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $1.63B

Enterprise Value $1.36B

Beta 0.41

Average Volume 596.16K

Shares Outstanding (Diluted) 28.69M

Shares Change YoY -6.37%

Institutional Ownership N/A

Exchange NASDAQ

ISIN US0327241065

Price Performance

Price Change 1M -8.5%

Price Change 3M -8.0%

Price Change 6M 32.0%

Price Change YTD 84.2%

Price Change 1Y 292.9%

Price Change 3Y 390.7%

Price Change 5Y 202.8%

1M CAGR (ann.) 0.8%

1Y CAGR (ann.) 317.9%

5Y CAGR (ann.) 26.3%

All-Time CAGR 17.8%

Valuation

PE Ratio -51.11

Forward PE 10.99

PEG Ratio 0.20

Forward PEG 0.28

PS Ratio 7.03

Forward PS 10.30

PB Ratio 128.22

P/FCF Ratio 370.69

P/Adj. FCF Ratio -44.52

P/OCF Ratio 345.00

EV/Sales 5.86

EV/EBIT 26.75

EV/EBITDA 25.82

EV/FCF 308.81

Earnings Yield -2.0%

FCF Yield 0.3%

Adj. FCF Yield -2.3%

Financial Health

Net Cash $272.84M

Total Debt $13.61M

Cash & Short-Term Investments $286.46M

Total Assets $329.68M

Current Ratio 7.58

Quick Ratio 7.58

Debt / Equity Ratio 21.76

Debt / EBITDA 0.26

Debt / FCF 3.09

OCF / Debt 0.33

Interest Coverage 0.49

Altman Z-Score 1.80

Piotroski F-Score 6

Margins & Profitability

Gross Profit Margin 116.4%

Operating Profit Margin 17.6%

EBITDA Margin 25.2%

Net Profit Margin -11.5%

FCF Margin 1.9%

Adj. FCF Margin -15.8%

SBC / Revenue 17.7%

SBC Impact (per share) -932.6%

Returns

Return on Assets -8.1%

Return on Equity 442.9%

Return on Invested Capital 14.1%

Return on Capital Employed 14.2%

Return on Tangible Assets -8.1%

Historical Growth (CAGR)

Revenue CAGR 3Y 179.1%

Revenue CAGR 5Y 26.7%

Revenue CAGR 10Y 28.9%

EPS CAGR 3Y 62.5%

EPS CAGR 5Y 10.0%

EPS CAGR 10Y -10.3%

FCF CAGR 3Y 87.0%

FCF CAGR 5Y 9.3%

FCF CAGR 10Y -9.7%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 23

EPS Growth Next 3Y 264.7%

Revenue Growth Next 3Y 14.6%

Earnings Date Sep 22, 2026

EPS Estimate (next Q) -$0.47

EPS Growth Est (next Q) N/A

Revenue Est (next Q) $14.06M

Revenue Growth Est (next Q) -36.9%

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $77.80

Price Target Upside 40.9%

Cash Flow

Operating Cash Flow $4.48M

Free Cash Flow $4.41M

Adj. Free Cash Flow $-36.71M

FCF Per Share $0.15

OCF Per Share $0.16

OCF/S Ratio 1.9%

Income Statement

Revenue $232.39M

Gross Profit $270.54M

Operating Income $40.8M

EBITDA $52.72M

Net Income $-26.79M

EPS (Diluted) -$1.08

Revenue / Employee $2.23M

Profit / Employee $-257.57K

Employees 104